MediaPress Releases
 January 23, 2012

Sg2 Appoints Eric Louie as Chief Medical Officer

SKOKIE, IL–(Marketwire – Jan 23, 2012) – Sg2, a health care intelligence, analytics, and consulting company, today announced the appointment of Eric Louie, MD, FACP, FACC, MBA as chief medical officer. With over 15 years of experience, Louie will work closely with Sg2’s clients to introduce and implement Sg2’s latest analyses and insights, ultimately enabling health care organizations to build a competitive value-driven strategy for success today and in the future.

Louie joined Sg2 in 2004 leading strategic planning, forecasting, program optimization and facility design projects for Sg2 consulting customers. In addition, he contributed to the thought leadership of Sg2’s Cardiovascular and International teams. He has worked with a wide range of domestic and international customers, including academic medical centers, integrated health care delivery networks, ambulatory health care systems, medical device companies, professional medical societies and governmental payers. His customers have ranged from complex urban health care institutions to rural critical access hospitals.

“Eric brings a wealth of medical, clinical and consulting experience which will be extremely valuable to our clients,” said Steve Lefar, president, Sg2. “The depth and breadth of Sg2’s clinical and strategic expertise is unparalleled and Eric is a welcome addition to our senior leadership team. He will help us further enhance our business intelligence and educational programs, delivering measurable value across the full continuum of health care services.”

Louie has more than 15 years of experience as a clinical cardiologist on the faculties of the Uniformed Services University of the Health Sciences, University of Illinois and Loyola University Chicago. While a tenured professor of medicine at Loyola, he served as the associate director of the cardiology division. Louie has also led strategy engagements for ZS Associates, a management consulting firm specializing in pharmaceutical sales force and marketing strategies. Before joining Sg2, he directed the medicine and neurology service lines of the Edward Hines Jr VA Hospital in Hines, IL.

After receiving his AB, summa cum laude, in biochemical sciences from Harvard College, Louie completed his MD at Harvard Medical School. He trained in internal medicine at the Brigham and Women’s Hospital, in cardiovascular diseases at the University of Chicago and in cardiovascular imaging research at the National Institutes of Health. He is board certified in internal medicine and cardiovascular diseases and holds fellowships in the American College of Physicians, the American College of Cardiology, the Council on Clinical Cardiology of the American Heart Association and the Royal Society of Medicine in London. In 2001, Louie completed his MBA at the Kellogg School of Management at Northwestern University.

“I am thrilled to be a part of the Sg2 executive leadership team and continue to be part of a brand that is built on expert-led, future-focused systems for health care,” said Louie. “As health care shifts from a volume- to value-based market, strategic planning must adapt accordingly. Sg2 has always focused on helping our clients optimize performance and find innovative growth strategies to ensure success.”

On February 21 at 11:00 am CT, Dr. Louie will discuss Sg2’s unique perspective on the massive changes impacting the health care industry during a Web seminar titled Value-Driven Strategy: The Virtuous Cycle of Growth and Performance. Along with his co-host, Sg2 strategic planning expert Steve Jenkins, Dr. Louie will explore how hospitals and health systems can find success by capitalizing on the increasing interdependence between superior clinical performance and strong growth.

For additional information on Sg2, please visit

About Sg2
For over a decade, Sg2 has equipped health care leadership teams around the globe with practical expertise to navigate the ever changing landscape of health care. Our expert-led, future-focused forecasts, strategic analytics, education, consulting and intelligence empower clients to achieve smart growth and improve clinical performance across the continuum of care. Presently, over 1,400 individual organizations receive Sg2’s health care analytics, intelligence, consulting and educational services. These organizations are spread throughout the US, Europe and Asia. For more information, visit

  • Share
  • Follow Sg2 on Facebook
  • Follow Sg2 on Twitter
  • Connect with Sg2 on LinkedIn
"Analytics and expertise to help you understand market dynamics and capitalize opportunities for growth."

As of February 11, 2016, Vizient, Inc. has completed its purchase of MedAssets Sg2 and spend and clinical resource management segments from Pamplona Capital Management, LLC. MedAssets revenue cycle business will continue to operate as a wholly-owned subsidiary of Pamplona Capital Management LLP.

Follow Sg2 on Facebook Follow Sg2 on Twitter Connect with Sg2 on LinkedIn Watch Sg2 on YouTube